Skip to main content
Erschienen in: Journal of Neurology 6/2014

01.06.2014 | Original Communication

Cognitive and autonomic dysfunction in presymptomatic and early Huntington’s disease

verfasst von: Jan Kobal, Ziva Melik, Ksenija Cankar, Martin Strucl

Erschienen in: Journal of Neurology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Huntington’s disease is characterized by disorders of movement, cognition and behavior. Individuals with Huntington’s disease display aberrant changes in the autonomic nervous system that are detected even before the onset of other symptoms. Subtle cognitive dysfunction may start before other clinical manifestations. The aim of the present study was to investigate the autonomic nervous system response to mental arithmetic and the relationship between the autonomic and cognitive/motor function in presymptomatic and early Huntington’s disease. We examined 15 presymptomatic Huntington’s disease gene carriers (PHD), 15 early Huntington’s disease patients (EHD) and 30 healthy controls. PHD and EHD groups were determined according to Unified Huntington’s Disease Rating Scale (UHDRS) motor score. ECG, heart rate, systolic and diastolic blood pressure, and cutaneous laser Doppler flux were measured during rest and during a simple mental arithmetic test. UHDRS cognitive test battery was applied to determine cognitive dysfunction. During mental arithmetic, the heart rate of PHD/EHD increased significantly less than that of controls. Decreased microvascular response to mental arithmetic was found in EHD. Significant correlations for the PHD/EHD group were found between laser Doppler flux response and Symbol Digit Modalities Test score, and between laser Doppler flux response and UHDRS motor score. It seems that central autonomic dysregulation of cardiovascular system in Huntington’s disease goes along with the degeneration of other central neuronal systems. This finding is relevant as it could enable simple and noninvasive testing of disease progression.
Literatur
1.
Zurück zum Zitat Gutekunst CA, Norflus F, Hersch SM (2002) The neuropathology of Huntington’s disease. In: Bates G, Harper PS, Jones L (eds) Huntington’s disease. Oxford University Press, New York, pp 251–275 Gutekunst CA, Norflus F, Hersch SM (2002) The neuropathology of Huntington’s disease. In: Bates G, Harper PS, Jones L (eds) Huntington’s disease. Oxford University Press, New York, pp 251–275
2.
Zurück zum Zitat Den Heijer JC, Bollen WL, Reulenm JP (1988) Autonomic nervous function in Huntington’s disease. Arch Neurol 45:309–312CrossRef Den Heijer JC, Bollen WL, Reulenm JP (1988) Autonomic nervous function in Huntington’s disease. Arch Neurol 45:309–312CrossRef
3.
Zurück zum Zitat Kobal J, Meglic B, Mesec A et al (2004) Early sympathetic hyperactivity in Huntington’s disease. Eur J Neurol 11:842–848CrossRefPubMed Kobal J, Meglic B, Mesec A et al (2004) Early sympathetic hyperactivity in Huntington’s disease. Eur J Neurol 11:842–848CrossRefPubMed
4.
Zurück zum Zitat Kremer B (2002) Clinical neurology of Huntington’s disease. Diversity in unity, unity in diversity. In: Bates G, Harper PS, Jones L (eds) Huntington’s disease. Oxford University Press, New York, pp 28–61 Kremer B (2002) Clinical neurology of Huntington’s disease. Diversity in unity, unity in diversity. In: Bates G, Harper PS, Jones L (eds) Huntington’s disease. Oxford University Press, New York, pp 28–61
5.
Zurück zum Zitat Kirkwood SC, Siemers E, Hodes ME et al (2000) Subtle changes among presymptomatic carriers of the Huntington’s disease gene. J Neurol Neurosurg Psychiatry 69:773–779PubMedCentralCrossRefPubMed Kirkwood SC, Siemers E, Hodes ME et al (2000) Subtle changes among presymptomatic carriers of the Huntington’s disease gene. J Neurol Neurosurg Psychiatry 69:773–779PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Begeti F, Tan AYK, Cummins GA et al (2013) The Addenbrooke’s cognitive examination-revised accurately detects cognitive decline in Huntington’s disease. J Neurol 260:2777–2785CrossRefPubMed Begeti F, Tan AYK, Cummins GA et al (2013) The Addenbrooke’s cognitive examination-revised accurately detects cognitive decline in Huntington’s disease. J Neurol 260:2777–2785CrossRefPubMed
7.
Zurück zum Zitat Wolf RC, Sambataro F, Vasic N et al (2008) Altered frontostriatal coupling in pre-manifest Huntington’s disease: effects of increasing cognitive load. Eur J Neurol 15:1180–1190CrossRefPubMed Wolf RC, Sambataro F, Vasic N et al (2008) Altered frontostriatal coupling in pre-manifest Huntington’s disease: effects of increasing cognitive load. Eur J Neurol 15:1180–1190CrossRefPubMed
8.
Zurück zum Zitat Paulsen JS, Zimbelman JL, Hinton SC et al (2004) fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington’s disease. Am J Neuroradiol 25:1715–1721PubMed Paulsen JS, Zimbelman JL, Hinton SC et al (2004) fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington’s disease. Am J Neuroradiol 25:1715–1721PubMed
9.
Zurück zum Zitat Rosas HD, Salat DH, Lee SY et al (2008) Cerebral cortex and the clinical expression of Huntington’s disease: complexity and heterogeneity. Brain 131:1057–1068PubMedCentralCrossRefPubMed Rosas HD, Salat DH, Lee SY et al (2008) Cerebral cortex and the clinical expression of Huntington’s disease: complexity and heterogeneity. Brain 131:1057–1068PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Rosas HD, Hevelone ND, Zaleta AK et al (2005) Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 65:745–747CrossRefPubMed Rosas HD, Hevelone ND, Zaleta AK et al (2005) Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 65:745–747CrossRefPubMed
11.
Zurück zum Zitat Wolf RC, Vasic N, Schönfeldt-Lecuona C et al (2007) Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington’s disease: evidence from event-related fMRI. Brain 130:2845–2857CrossRefPubMed Wolf RC, Vasic N, Schönfeldt-Lecuona C et al (2007) Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington’s disease: evidence from event-related fMRI. Brain 130:2845–2857CrossRefPubMed
12.
Zurück zum Zitat Aziz NA, Anguelova GV, Marinus J et al (2010) Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington’s disease. Eur J Neurol 17:1068–1074CrossRefPubMed Aziz NA, Anguelova GV, Marinus J et al (2010) Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington’s disease. Eur J Neurol 17:1068–1074CrossRefPubMed
13.
Zurück zum Zitat Andrich J, Schmitz T, Saft C et al (2002) Autonomic nervous system function in Huntington’s disease. J Neurol Neurosurg Psychiatry 72:726–731PubMedCentralCrossRefPubMed Andrich J, Schmitz T, Saft C et al (2002) Autonomic nervous system function in Huntington’s disease. J Neurol Neurosurg Psychiatry 72:726–731PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Kobal J, Melik Z, Cankar K et al (2010) Autonomic dysfunction in presymptomatic and early symptomatic Huntington’s disease. Acta Neurol Scand 121:392–399CrossRefPubMed Kobal J, Melik Z, Cankar K et al (2010) Autonomic dysfunction in presymptomatic and early symptomatic Huntington’s disease. Acta Neurol Scand 121:392–399CrossRefPubMed
15.
Zurück zum Zitat Melik Z, Kobal J, Cankar K et al (2012) Microcirculation response to local cooling in patients with Huntington’s disease. J Neurol 295:921–928CrossRef Melik Z, Kobal J, Cankar K et al (2012) Microcirculation response to local cooling in patients with Huntington’s disease. J Neurol 295:921–928CrossRef
16.
Zurück zum Zitat Bennaroch EE (1993) The central autonomic network: functional organisation, dysfunction and perspective. Mayo Clin Proc 68:988–1001CrossRef Bennaroch EE (1993) The central autonomic network: functional organisation, dysfunction and perspective. Mayo Clin Proc 68:988–1001CrossRef
17.
Zurück zum Zitat Aylward EH, Nopoulos PC, Ross CA et al (2011) Longitudinal change in regional brain volumes in prodromal Huntington’s disease. J Neurol Neurosurg Psychiatry 82:405–410PubMedCentralCrossRefPubMed Aylward EH, Nopoulos PC, Ross CA et al (2011) Longitudinal change in regional brain volumes in prodromal Huntington’s disease. J Neurol Neurosurg Psychiatry 82:405–410PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Peckerman A, la Manca JJ, Smith SL (2000) Cardiovascular stress responses and their relation to symptoms of gulf war veterans with fatiguing illness. Psychosom Med 62:509–516CrossRefPubMed Peckerman A, la Manca JJ, Smith SL (2000) Cardiovascular stress responses and their relation to symptoms of gulf war veterans with fatiguing illness. Psychosom Med 62:509–516CrossRefPubMed
19.
20.
Zurück zum Zitat Huntington Study Group (1996) Unified Huntington’s disease rating scale: reliability and consistency. Mov Disord 11:135–142 Huntington Study Group (1996) Unified Huntington’s disease rating scale: reliability and consistency. Mov Disord 11:135–142
21.
Zurück zum Zitat Yvonne-Tee GB, Rasool AH, Halim AS et al (2006) Noninvasive assessment of cuteneous vascular function in vivo using capillaroscopy, pletismography and Laser-Doppler instruments; its strengths and weaknesses. Clin Hemorheol Microcirc 34:457–473PubMed Yvonne-Tee GB, Rasool AH, Halim AS et al (2006) Noninvasive assessment of cuteneous vascular function in vivo using capillaroscopy, pletismography and Laser-Doppler instruments; its strengths and weaknesses. Clin Hemorheol Microcirc 34:457–473PubMed
22.
Zurück zum Zitat Snowden JS, Craufurd D, Thompson J et al (2002) Psychomotor, executive and memory function in preclinical Huntington’s disease. J Clin Exp Neuropsychol 24:133–145CrossRefPubMed Snowden JS, Craufurd D, Thompson J et al (2002) Psychomotor, executive and memory function in preclinical Huntington’s disease. J Clin Exp Neuropsychol 24:133–145CrossRefPubMed
23.
Zurück zum Zitat Paulsen JS, Smith MM, Long JD, the PREDICT investigators and coordinators of the Huntington Study Group (2013) Cognitive decline in prodromal Huntington Disease: implications for clinical trials. J Neurol Neurosurg Psychiatry 84:1233–1239CrossRef Paulsen JS, Smith MM, Long JD, the PREDICT investigators and coordinators of the Huntington Study Group (2013) Cognitive decline in prodromal Huntington Disease: implications for clinical trials. J Neurol Neurosurg Psychiatry 84:1233–1239CrossRef
24.
Zurück zum Zitat The Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983CrossRef The Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983CrossRef
25.
Zurück zum Zitat Tonkin AL, Frewin DB (2002) Drugs, chemicals and toxins that alter autonomic function. In: Mathias CJ, Bannister R (eds) Autonomic failure. Oxford University Press, Oxford, pp 527–533 Tonkin AL, Frewin DB (2002) Drugs, chemicals and toxins that alter autonomic function. In: Mathias CJ, Bannister R (eds) Autonomic failure. Oxford University Press, Oxford, pp 527–533
26.
Zurück zum Zitat Low PA, Pfeiffer MA (1993) Standardization of clinical tests for practice and clinical trials. In: Low PA (ed) Clinical autonomic disorders: evaluation and management. Little Brown, Boston, pp 728–745 Low PA, Pfeiffer MA (1993) Standardization of clinical tests for practice and clinical trials. In: Low PA (ed) Clinical autonomic disorders: evaluation and management. Little Brown, Boston, pp 728–745
27.
Zurück zum Zitat Malik M (1996) Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93:1043–1065CrossRef Malik M (1996) Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93:1043–1065CrossRef
28.
Zurück zum Zitat Stein PK, Kleiger RE (1999) Insights from the study of heart rate variability. Annu Rev Med 50:249–261CrossRefPubMed Stein PK, Kleiger RE (1999) Insights from the study of heart rate variability. Annu Rev Med 50:249–261CrossRefPubMed
29.
Zurück zum Zitat Parati G, Di Renzo M, Mancia G (2000) How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens 18:7–19CrossRefPubMed Parati G, Di Renzo M, Mancia G (2000) How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens 18:7–19CrossRefPubMed
30.
Zurück zum Zitat Ostergren J, Kahan T, Hjemdahl P et al (1992) Effects of sympatho-adrenal activation on the finger microcirculation in mild hypertension. J Hum Hypertens 6:169–173PubMed Ostergren J, Kahan T, Hjemdahl P et al (1992) Effects of sympatho-adrenal activation on the finger microcirculation in mild hypertension. J Hum Hypertens 6:169–173PubMed
31.
Zurück zum Zitat Thomaides TN, Zoukos Y, Chauhuri KR et al (1993) Physiological assessment of aspects of autonomic function in patients secondary progressive multiple sclerosis. J Neurol 240:139–143CrossRefPubMed Thomaides TN, Zoukos Y, Chauhuri KR et al (1993) Physiological assessment of aspects of autonomic function in patients secondary progressive multiple sclerosis. J Neurol 240:139–143CrossRefPubMed
32.
Zurück zum Zitat Jänig W, Häbler HJ (2003) Neurophysiological analysis of target-related sympathetic pathways—from animal to human: similarities and differences. Acta Physiol Scand 177:255–274CrossRefPubMed Jänig W, Häbler HJ (2003) Neurophysiological analysis of target-related sympathetic pathways—from animal to human: similarities and differences. Acta Physiol Scand 177:255–274CrossRefPubMed
33.
Zurück zum Zitat Paulsen JS, Nopopulos PC, Aylward E et al (2010) Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 82:201–207PubMedCentralCrossRefPubMed Paulsen JS, Nopopulos PC, Aylward E et al (2010) Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 82:201–207PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Rosas HD, Reuter M, Doros G et al (2011) A tale of two factors: what determines rate of progression in Huntington disease? A longitudinal MRI study. Mov Disord 26:1691–1697PubMedCentralCrossRefPubMed Rosas HD, Reuter M, Doros G et al (2011) A tale of two factors: what determines rate of progression in Huntington disease? A longitudinal MRI study. Mov Disord 26:1691–1697PubMedCentralCrossRefPubMed
35.
Zurück zum Zitat Squitieri F, Cannella M, Giallonardo P et al (2001) Onset and pre-onset studies to define the Huntington’s disease natural history. Brain Res Bull 56:233–238CrossRefPubMed Squitieri F, Cannella M, Giallonardo P et al (2001) Onset and pre-onset studies to define the Huntington’s disease natural history. Brain Res Bull 56:233–238CrossRefPubMed
36.
Zurück zum Zitat Sprengelmeyer R, Orth M, Müller HP et al (2013) The neuroanatomy of subthreshold depressive symptoms in Huntington’s disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study. Psychol Med 7:1–12 [Epub ahead of print] Sprengelmeyer R, Orth M, Müller HP et al (2013) The neuroanatomy of subthreshold depressive symptoms in Huntington’s disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study. Psychol Med 7:1–12 [Epub ahead of print]
37.
Zurück zum Zitat Li SH, Li XJ (2004) Huntingtin and its role in neuronal degeneration. Neuroscientist 10:467–475CrossRefPubMed Li SH, Li XJ (2004) Huntingtin and its role in neuronal degeneration. Neuroscientist 10:467–475CrossRefPubMed
Metadaten
Titel
Cognitive and autonomic dysfunction in presymptomatic and early Huntington’s disease
verfasst von
Jan Kobal
Ziva Melik
Ksenija Cankar
Martin Strucl
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 6/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7319-6

Weitere Artikel der Ausgabe 6/2014

Journal of Neurology 6/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.